tiprankstipranks
IntelGenx Technologies (IGXT)
OTHER OTC:IGXT

IntelGenx Technologies (IGXT) Stock Price & Analysis

146 Followers

IGXT Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.09 - $0.26
Previous Close$0.18
Volume46.39K
Average Volume (3M)91.11K
Market Cap
$32.14M
Enterprise Value$45.60M
Total Cash (Recent Filing)$2.08M
Total Debt (Recent Filing)$15.54M
Price to Earnings (P/E)-3.2
Beta1.63
May 09, 2024
EPS EstimateN/A
Next Dividend Ex-DateN/A
Expense RatioN/A
Share Statistics
EPS (TTM)-0.06
Shares Outstanding174,658,096
10 Day Avg. Volume98,356
30 Day Avg. Volume91,106
Standard Deviation0.24
R-Squared0.28
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)-2.89
Price to Sales (P/S)33.83
Price to Cash Flow (P/CF)-5.50
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue74.38
Enterprise Value/Gross Profit47.99
Enterprise Value/Ebitda-6.60
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Ownership Overview

43.32%0.00%<0.01%56.68%
43.32%
Insiders
<0.01% Other Institutional Investors
56.68% Public Companies and
Individual Investors

Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

IGXT FAQ

What was IntelGenx Technologies’s price range in the past 12 months?
IntelGenx Technologies lowest stock price was $0.09 and its highest was $0.26 in the past 12 months.
    What is IntelGenx Technologies’s market cap?
    Currently, no data Available
    When is IntelGenx Technologies’s upcoming earnings report date?
    IntelGenx Technologies’s upcoming earnings report date is May 09, 2024 which is in 41 days.
      How were IntelGenx Technologies’s earnings last quarter?
      IntelGenx Technologies released its earnings results on Mar 21, 2024. The company reported -$0.008 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.008.
        Is IntelGenx Technologies overvalued?
        According to Wall Street analysts IntelGenx Technologies’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does IntelGenx Technologies pay dividends?
          IntelGenx Technologies does not currently pay dividends.
          What is IntelGenx Technologies’s EPS estimate?
          IntelGenx Technologies’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does IntelGenx Technologies have?
          IntelGenx Technologies has 174,658,100 shares outstanding.
            What happened to IntelGenx Technologies’s price movement after its last earnings report?
            IntelGenx Technologies reported an EPS of -$0.008 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
              Which hedge fund is a major shareholder of IntelGenx Technologies?
              Currently, no hedge funds are holding shares in IGXT
              ---

              IntelGenx Technologies Stock Smart Score

              N/A
              Not Ranked
              1
              2
              3
              4
              5
              6
              7
              8
              9
              10

              Technicals

              SMA
              Positive
              20 days / 200 days
              Momentum
              3.37%
              12-Months-Change

              Fundamentals

              Return on Equity
              Trailing 12-Months
              Asset Growth
              -9.88%
              Trailing 12-Months

              Company Description

              IntelGenx Technologies

              IntelGenx Technologies Corp. is a oral drug delivery company, which focuses on the development and manufacturing of pharmaceutical oral films based on its proprietary VersaFilm technology platform. Its products include rizaport, tadalafil, loxapine, and montelukast. The company also offers a comprehensive portfolio of pharmaceutical services, such as pharmaceutical research & development, clinical monitoring, regulatory support, tech transfer & manufacturing scale-up and commercial manufacturing. IntelGenx Technologies was founded on July 27, 1999 and is headquartered in Ville Saint-Laurent, Canada.
              ---
              Similar Stocks
              Company
              Price & Change
              Follow
              Aptose Biosciences
              Sintx Technologies
              Oncolytics Biotech
              Eton Pharmaceuticals
              Popular Stocks
              ---
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis